Skip to main content
Accuray Incorporated (ARAY)
NASDAQ: ARAY · Real-Time Price · USD
1.850
+0.060 (3.35%)
Dec 20, 2024, 4:00 PM EST - Market closed

Accuray Revenue

Accuray had revenue of $101.55M in the quarter ending September 30, 2024, a decrease of -2.26%. This brings the company's revenue in the last twelve months to $444.20M, down -2.37% year-over-year. In the fiscal year ending June 30, 2024, Accuray had annual revenue of $446.55M, down -0.24%.

Revenue (ttm)
$444.20M
Revenue Growth
-2.37%
P/S Ratio
0.41
Revenue / Employee
$450,055
Employees
987
Market Cap
186.05M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2024446.55M-1.05M-0.24%
Jun 30, 2023447.61M17.70M4.12%
Jun 30, 2022429.91M33.62M8.48%
Jun 30, 2021396.29M13.36M3.49%
Jun 30, 2020382.93M-35.86M-8.56%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coherus BioSciences 304.34M
Amarin Corporation 241.02M
InfuSystem Holdings 132.78M
Nektar Therapeutics 93.14M
Genfit 86.23M
ADC Therapeutics 70.72M
Alector 61.51M
MediWound 19.72M
Revenue Rankings

ARAY News

More News